MBB Public Markets I LLC Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

MBB Public Markets I LLC decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.5% in the 2nd quarter, Holdings Channel reports. The fund owned 245,619 shares of the exchange traded fund’s stock after selling 67,279 shares during the quarter. MBB Public Markets I LLC’s holdings in SPDR S&P Biotech ETF were worth $22,771,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Dimension Capital Management LLC boosted its position in SPDR S&P Biotech ETF by 28.5% during the second quarter. Dimension Capital Management LLC now owns 15,311 shares of the exchange traded fund’s stock worth $1,419,000 after purchasing an additional 3,396 shares during the period. Employees Retirement System of Texas lifted its stake in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after buying an additional 174,857 shares in the last quarter. Affinity Asset Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after buying an additional 737,550 shares during the period. Prairie Wealth Advisors Inc. grew its stake in SPDR S&P Biotech ETF by 3.6% in the 2nd quarter. Prairie Wealth Advisors Inc. now owns 6,616 shares of the exchange traded fund’s stock valued at $613,000 after buying an additional 231 shares in the last quarter. Finally, Toronto Dominion Bank raised its holdings in SPDR S&P Biotech ETF by 16.3% during the 2nd quarter. Toronto Dominion Bank now owns 21,743 shares of the exchange traded fund’s stock valued at $2,016,000 after acquiring an additional 3,048 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $98.18 on Friday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock’s fifty day moving average price is $98.92 and its two-hundred day moving average price is $93.96. The company has a market cap of $7.48 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.